To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
"Biosimilars for Employer Consultants" was created to provide background information on biosimilars and to provide considerations for consultants to discuss with their employer clients.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.